コンパニオンアニマルワクチン市場レポート：2030年までの動向、予測、競合分析

コンパニオンアニマルワクチンの動向と予測

コンパニオンアニマルワクチンの世界市場は、2024年から2030年までのCAGRが6.3%で、2030年までに推定48億米ドルに達すると予想されています。この市場の主な促進要因は、ペットワクチン接種の重要性に対する意識の高まり、人獣共通感染症の症例の増加、そして世界におけるペット飼育への関心の高まりです。コンパニオンアニマルワクチンの世界市場の将来は、病院とクリニック市場や研究機関市場における機会によって有望視されています。

コンパニオンアニマルワクチン市場洞察

Lucintelは、ペットを深刻な病気から守るためのワクチン接種の重要性に対する飼い主の意識の高まりにより、イヌ科が最大のセグメントであり続けると予測しています。

この市場の中では、病院とクリニックが予測期間中に最も高い成長を遂げると予測されています。

北米はペットの飼育率が高く、同地域の人々の間でペットワクチン接種の重要性に対する認識が高まっているため、今後も最大地域であり続けると思われます。

市場規模・推定：コンパニオンアニマルワクチンの市場規模を金額（10億米ドル）で推定。

動向と予測分析：様々なセグメントと地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

セグメンテーション分析：コンパニオンアニマルワクチンの製品タイプ別、動物種タイプ別、最終用途別、地域別の市場規模（金額（10億米ドル））。

地域別分析：コンパニオンアニマルワクチン市場の北米、欧州、アジア太平洋、その他世界のその他の中東・アフリカ内訳。

成長機会：コンパニオンアニマルワクチン市場の製品タイプ、動物種、最終用途、地域別の成長機会分析。

戦略的分析：これにはコンパニオンアニマルワクチン市場のM&A、新製品開発、競合情勢が含まれます。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のコンパニオンアニマルワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のコンパニオンアニマルワクチン市場動向（2018～2023）と予測（2024～2030）
• 製品タイプ別の世界のコンパニオンアニマルワクチン市場
  • 弱毒化生
  • 結合型
  • 不活化
  • サブユニット
  • トキソイド
  • DNA
  • 組換え
• 種タイプ別の世界のコンパニオンアニマルワクチン市場
  • イヌ科
  • 鳥類
  • ネコ科
  • 馬
• 最終用途別の世界のコンパニオンアニマルワクチン市場
  • 病院とクリニック
  • 研究機関
  • その他

第4章 2018～2030年の地域別の市場動向と予測分析

• 地域別の世界のコンパニオンアニマルワクチン市場
• 北米のコンパニオンアニマルワクチン市場
• 欧州のコンパニオンアニマルワクチン市場
• アジア太平洋のコンパニオンアニマルワクチン市場
• その他地域のコンパニオンアニマルワクチン市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 製品タイプ別の世界のコンパニオンアニマルワクチン市場の成長機会
  • 種タイプ別の世界のコンパニオンアニマルワクチン市場の成長機会
  • 最終用途別の世界のコンパニオンアニマルワクチン市場の成長機会
  • 地域別の世界のコンパニオンアニマルワクチン市場の成長機会
• 世界のコンパニオンアニマルワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のコンパニオンアニマルワクチン市場の能力拡大
  • 世界のコンパニオンアニマルワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences

Companion Animal Vaccine Trends and Forecast

The future of the global companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets. The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

A more than 150-page report is developed to help in your business decisions.

Companion Animal Vaccine by Segment

The study includes a forecast for the global companion animal vaccine by product type, species type, end use, and region.

Companion Animal Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Attenuated Live
• Conjugate
• Inactivated
• Subunit
• Toxoid
• DNA
• Recombinant

Companion Animal Vaccine Market by Species Type [Shipment Analysis by Value from 2018 to 2030]:

• Canine
• Avian
• Feline
• Equine

Companion Animal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Research Institutes
• Others

Companion Animal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Companion Animal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies companion animal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the companion animal vaccine companies profiled in this report include-

• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences

Companion Animal Vaccine Market Insights

Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Within this market, hospital & clinic is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Features of the Global Companion Animal Vaccine Market

Market Size Estimates: Companion animal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Companion animal vaccine market size by product type, species type, end use, and region in terms of value ($B).

Regional Analysis: Companion animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, species types, end uses, and regions for the companion animal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the companion animal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the companion animal vaccine market size?

Answer: The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030.

Q.2 What is the growth forecast for companion animal vaccine market?

Answer: The global companion animal vaccine market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the companion animal vaccine market?

Answer: The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

Q4. What are the major segments for companion animal vaccine market?

Answer: The future of the companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets.

Q5. Who are the key companion animal vaccine market companies?

Answer: Some of the key companion animal vaccine companies are as follows:

• Elanco
• Boehringer Ingelheim International
• Intervet
• Zoetis Services
• Bioveta
• Sanofi
• Bayer
• Heska
• Virbac
• Hester Biosciences

Q6. Which companion animal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Q7. In companion animal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the companion animal vaccine market by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), end use (hospitals & clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Companion Animal Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Companion Animal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Companion Animal Vaccine Market by Product Type
  • 3.3.1: Attenuated Live
  • 3.3.2: Conjugate
  • 3.3.3: Inactivated
  • 3.3.4: Subunit
  • 3.3.5: Toxoid
  • 3.3.6: DNA
  • 3.3.7: Recombinant
• 3.4: Global Companion Animal Vaccine Market by Species Type
  • 3.4.1: Canine
  • 3.4.2: Avian
  • 3.4.3: Feline
  • 3.4.4: Equine
• 3.5: Global Companion Animal Vaccine Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Research Institutes
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Companion Animal Vaccine Market by Region
• 4.2: North American Companion Animal Vaccine Market
  • 4.2.1: North American Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
  • 4.2.2: North American Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
• 4.3: European Companion Animal Vaccine Market
  • 4.3.1: European Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
  • 4.3.2: European Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
• 4.4: APAC Companion Animal Vaccine Market
  • 4.4.1: APAC Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
  • 4.4.2: APAC Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
• 4.5: ROW Companion Animal Vaccine Market
  • 4.5.1: ROW Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
  • 4.5.2: ROW Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Companion Animal Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Companion Animal Vaccine Market by Species Type
  • 6.1.3: Growth Opportunities for the Global Companion Animal Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Companion Animal Vaccine Market by Region
• 6.2: Emerging Trends in the Global Companion Animal Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Companion Animal Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Companion Animal Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco
• 7.2: Boehringer Ingelheim International
• 7.3: Intervet
• 7.4: Zoetis Services
• 7.5: Bioveta
• 7.6: Sanofi
• 7.7: Bayer
• 7.8: Heska
• 7.9: Virbac
• 7.10: Hester Biosciences